Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 2 |
2008 | 1 |
2009 | 1 |
2011 | 1 |
2012 | 2 |
2013 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Bisphosphonates in cancer therapy.
Cancer Lett. 2007 Nov 8;257(1):16-35. doi: 10.1016/j.canlet.2007.07.007. Epub 2007 Aug 13.
Cancer Lett. 2007.
PMID: 17697748
Review.
Treatment of bone metastasis in prostate cancer: efficacy of a novel polybisphosphonate.
Daubine F, LE Bot R, Márquez M, Nilsson S, Schröder T, Holmberg AR.
Daubine F, et al.
Anticancer Res. 2011 Dec;31(12):4141-5.
Anticancer Res. 2011.
PMID: 22199272
Item in Clipboard
Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention.
Daubiné F, Cortial D, Ladam G, Atmani H, Haïkel Y, Voegel JC, Clézardin P, Benkirane-Jessel N.
Daubiné F, et al.
Biomaterials. 2009 Oct;30(31):6367-73. doi: 10.1016/j.biomaterials.2009.08.002. Epub 2009 Aug 18.
Biomaterials. 2009.
PMID: 19692117
Item in Clipboard
Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.
Fretellier N, Idée J, Bruneval P, Guerret S, Daubiné F, Jestin G, Factor C, Poveda N, Dencausse A, Massicot F, Laprévote O, Mandet C, Bouzian N, Port M, Corot C.
Fretellier N, et al. Among authors: daubine f.
Br J Pharmacol. 2012 Feb;165(4b):1151-62. doi: 10.1111/j.1476-5381.2011.01585.x.
Br J Pharmacol. 2012.
PMID: 21740412
Free PMC article.
Item in Clipboard
Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
Fretellier N, Bouzian N, Parmentier N, Bruneval P, Jestin G, Factor C, Mandet C, Daubiné F, Massicot F, Laprévote O, Hollenbeck C, Port M, Idée JM, Corot C.
Fretellier N, et al. Among authors: daubine f.
Toxicol Sci. 2013 Jan;131(1):259-70. doi: 10.1093/toxsci/kfs274. Epub 2012 Sep 12.
Toxicol Sci. 2013.
PMID: 22977165
Item in Clipboard
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
Daubiné F, Le Gall C, Gasser J, Green J, Clézardin P.
Daubiné F, et al.
J Natl Cancer Inst. 2007 Feb 21;99(4):322-30. doi: 10.1093/jnci/djk054.
J Natl Cancer Inst. 2007.
PMID: 17312309
Item in Clipboard
Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo.
Fournier PG, Daubiné F, Lundy MW, Rogers MJ, Ebetino FH, Clézardin P.
Fournier PG, et al. Among authors: daubine f.
Cancer Res. 2008 Nov 1;68(21):8945-53. doi: 10.1158/0008-5472.CAN-08-2195.
Cancer Res. 2008.
PMID: 18974139
Item in Clipboard
Cite
Cite